Prot #017001: A Phase 1, Multicenter, Open-Label Study of JCAR017, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells, for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL)

Project: Research project

Project Details

StatusActive
Effective start/end date3/11/163/11/22

Funding

  • Juno Therapeutics, Inc. (Prot #017001)